Cbfb Deficiency Results in Differentiation Blocks and Stem/progenitor Cell Expansion in Hematopoiesis

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2014 Nov 6

PMID 25371180

Citations 10

Authors

C Q Wang

D W L Chin

J Y Chooi

W J Chng

I Taniuchi

V Tergaonkar

M Osato

Affiliations

Soon will be listed here.

Citing Articles

Intracellular zinc protects tumours from T cell-mediated cytotoxicity.

Lelliott E, Naddaf J, Ganio K, Michie J, Wang S, Liu L Cell Death Differ. 2024; 31(12):1707-1716.

PMID: 39261596 PMC: 11618339. DOI: 10.1038/s41418-024-01369-4.

Highly efficient Runx1 enhancer eR1-mediated genetic engineering for fetal, child and adult hematopoietic stem cells.

Koh C, Bahirvani A, Wang C, Yokomizo T, Ng C, Du L Gene. 2022; 851:147049.

PMID: 36384171 PMC: 10492510. DOI: 10.1016/j.gene.2022.147049.

Emerging therapies for inv(16) AML.

Surapally S, Tenen D, Pulikkan J Blood. 2021; 137(19):2579-2584.

PMID: 33821975 PMC: 8120144. DOI: 10.1182/blood.2020009933.

Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarking.

Rose J, Moskovitz E, Boyd J, Gordon J, Bouffard N, Fritz A Oncotarget. 2020; 11(26):2512-2530.

PMID: 32655837 PMC: 7335667. DOI: 10.18632/oncotarget.27637.

Platelet CD34 expression in a patient with a partial deletion of transcription factor subunit CBFB.

van Bergen M, Saes J, Simons A, Hebeda K, Henskens Y, Barteling W Am J Hematol. 2020; 95(6):E136-E139.

PMID: 32124467 PMC: 7317484. DOI: 10.1002/ajh.25770.

References

Mrozek K, Marcucci G, Nicolet D, Maharry K, Becker H, Whitman S . Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol. 2012; 30(36):4515-23. PMC: 3518729. DOI: 10.1200/JCO.2012.43.4738. View

Chen M, Yokomizo T, Zeigler B, Dzierzak E, Speck N . Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature. 2009; 457(7231):887-91. PMC: 2744041. DOI: 10.1038/nature07619. View

Wang Q, Stacy T, Miller J, Lewis A, Gu T, Huang X . The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell. 1996; 87(4):697-708. DOI: 10.1016/s0092-8674(00)81389-6. View

Liu P, Tarle S, Hajra A, Claxton D, Marlton P, Freedman M . Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science. 1993; 261(5124):1041-4. DOI: 10.1126/science.8351518. View

Castilla L, Wijmenga C, Wang Q, Stacy T, Speck N, Eckhaus M . Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell. 1996; 87(4):687-96. DOI: 10.1016/s0092-8674(00)81388-4. View

Growney J, Shigematsu H, Li Z, Lee B, Adelsperger J, Rowan R . Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood. 2005; 106(2):494-504. PMC: 1895175. DOI: 10.1182/blood-2004-08-3280. View

Jacob B, Osato M, Yamashita N, Wang C, Taniuchi I, Littman D . Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood. 2009; 115(8):1610-20. PMC: 2830765. DOI: 10.1182/blood-2009-07-232249. View

Speck N, Gilliland D . Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer. 2002; 2(7):502-13. DOI: 10.1038/nrc840. View

Taniuchi I, Osato M, Egawa T, Sunshine M, Bae S, Komori T . Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 2002; 111(5):621-33. DOI: 10.1016/s0092-8674(02)01111-x. View

10.

Wang C, Motoda L, Satake M, Ito Y, Taniuchi I, Tergaonkar V . Runx3 deficiency results in myeloproliferative disorder in aged mice. Blood. 2013; 122(4):562-6. DOI: 10.1182/blood-2012-10-460618. View

11.

Osato M . Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene. 2004; 23(24):4284-96. DOI: 10.1038/sj.onc.1207779. View

12.

de Pater E, Kaimakis P, Vink C, Yokomizo T, Yamada-Inagawa T, van der Linden R . Gata2 is required for HSC generation and survival. J Exp Med. 2013; 210(13):2843-50. PMC: 3865477. DOI: 10.1084/jem.20130751. View

13.

Kuo Y, Landrette S, Heilman S, Perrat P, Garrett L, Liu P . Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell. 2006; 9(1):57-68. DOI: 10.1016/j.ccr.2005.12.014. View

14.

Hyde R, Kamikubo Y, Anderson S, Kirby M, Alemu L, Zhao L . Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11. Blood. 2009; 115(7):1433-43. PMC: 2826765. DOI: 10.1182/blood-2009-06-227413. View

15.

Ley T, Miller C, Ding L, Raphael B, Mungall A, Robertson A . Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013; 368(22):2059-74. PMC: 3767041. DOI: 10.1056/NEJMoa1301689. View